These recommendations were systematically developed on behalf of the Network for Early
Onset Cystic Kidney Disease (NEOCYST) by an international group of experts in autosomal …

Background The definition of hematuria is the excretion of red blood cells (RBCs) in the
urine. A problem arising in the genitourinary tract anywhere from the glomerulus to the …

Abstract Background/Aims: Autosomal dominant polycystic kidney disease (ADPKD) is the
most common inherited kidney disorder with mutations in PKD1 or PKD2. This study aimed …

Objectives To conduct a systematic review of tranexamic acid (TXA) and the risk of renal
failure from urinary clots in adult patients with hematuria. Methods A systematic review of …

Autosomal dominant polycystic kidney disease (ADPKD) is considered as a tumor-like
disease because there are many biological similarities between ADPKD and cancer …

Purpose: Tranexamic acid is a fibrinolysis suppressor that is used for a variety of bleeding
control procedures such as hematuria, surgery bleeding, and trauma caused bleeding. The …

The achievement of rapid hemostasis represents a long-term trend in hemostatic research.
Specifically, composite materials are now the focus of attention, based on the given issues …

Background: Acute hemorrhage, both traumatic and nontraumatic, leads to significant
morbidity and mortality, both in the United States and globally. Traditional treatment of acute …

Safety and efficacy of transcatheter arterial embolization in autosomal dominant polycystic
kidney patients with gross hematuria: Six case reports - PMC Back to Top Skip to main content …

常染色体显性多囊肾病(autosomal dominant polycystic kidney disease, ADPKD)
是最常见的单基因遗传性肾病. 近年来, 几项大型临床随机对照试验表明, 托伐普坦(tolvaptan) …